Tumor Tracking Systems Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029

10.21%
CAGR (2023-2029)
2.98 USD Bn.
Market Size
303
Report Pages
150
Market Tables

Overview

Tumor Tracking Systems Market size is expected to grow at a CAGR of 10.21% during the forecast period and the market size is expected to reach nearly US$ 5.89 Bn. by 2029.

Tumor Tracking Systems Market Overview:

Tumor tracking systems are used to track the tumor in patient body. It is important for radiation therapy to deliver sufficient radiation dose without damaging the surrounding healthy tissue. Localization of tumor becomes difficult due to patient’s position shift, change of tumor area during series of treatment, and tumor movement due to respiration. Tumor Tracking Systems make imaging and radiotherapy more precise and safer for patients.Tumor Tracking Systems Market To Know About The Research Methodology :- Request Free Sample Report

Tumor Tracking Systems Market Dynamics:

Rising prevalence of tumor cancer and technological advancements drive the market growth.

Cancer is one of the leading causes of death globally. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. Use of technologically advanced devices like Calypso, which provides real-time tumor tracking with benefits such as no requirement of ionization radiation during localization of tumor. These devices help surgeons to perform treatment with minimal complications. Increasing research and development activities to find the cure for various cancer types and locate the tumor precisely further expected to drive the growth of the tumor tracking systems market.

The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.

Tumor Tracking Systems Market Segment Analysis:

The tumor tracking systems market is segmented on the basis of device type, application and end-user.

Based on Application, Prostate Cancer segment dominates the market as it is the second-highest form of cancer affecting men worldwide. As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. Due to such a high prevalence of prostate cancer, demand for tumor tracking is expected to rise during the forecast years.

Tumor Tracking Systems Market Regional Insights:

North America dominates the Tumor Tracking Systems Market.

The prevalence of prostate and breast cancer in the region is the major driving factor for the market growth. Increasing investments from the government in the use of biomarkers in drug discovery, detection of specific tumors and genetic studies for the identification of cancer propels the market growth in the region. Also, high awareness, availability of reimbursement policies, and high cost of the products in the U.S. propel the tumor tracking systems market in North America.

The report also helps in understanding Global Tumor Tracking Systems Market dynamics, structure by analyzing the market segments and projects the Global Tumor Tracking Systems Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Tumor Tracking Systems Market make the report investor’s guide.

Tumor Tracking Systems Market scope: Inquire before buying

Tumor Tracking Systems Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 2.98 Bn.
Forecast Period 2023 to 2029 CAGR: 10.21% Market Size in 2029: US $ 5.89 Bn.
Segments Covered: by Device Type • Direct Tumor Tracking Systems
• Respiratory Tracking Systems
by Application • Prostate Cancer
• Lung Cancer
• Breast Cancer
• Others
by End-Users • Hospitals
• Cancer Research Institutes
• Ambulatory Surgical Centers
• Others

Tumor Tracking Systems Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Tumor Tracking Systems Market Key Players:

• Varian Medical Systems, Inc.
• Accuray Incorporated
• Brainla
• Elekta AB
• Thermo Fisher Scientific
• Miltenyi Biotec
• Cell Biolabs, Inc.
• STEMCELL Technologies Inc.
• QIAGEN
• Genekam
• Menarini Silicon Biosystems, Inc.
• Koninklijke Philips N.V.
• CureMD Healthcare
• RaySearch Laboratories AB
• MICA Information Systems, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Tumor Tracking Systems Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Tumor Tracking Systems Market?
Ans: The Global Tumor Tracking Systems Market is growing at a CAGR of 10.21% during forecasting period 2023-2029.

3. What is scope of the Global Tumor Tracking Systems Market report?
Ans: Global Tumor Tracking Systems Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Tumor Tracking Systems Market?
Ans: The important key players in the Global Tumor Tracking Systems Market are – Varian Medical Systems, Inc., Accuray Incorporated, Brainla, Elekta AB, Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam, Menarini Silicon Biosystems, Inc., Koninklijke Philips N.V., CureMD Healthcare, RaySearch Laboratories AB, MICA Information Systems, Inc.

5. What is the study period of this Market?
Ans: The Global Tumor Tracking Systems Market is studied from 2022 to 2029.

Table of Contents

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Tumor Tracking Systems Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Tumor Tracking Systems Market 3.4. Geographical Snapshot of the Tumor Tracking Systems Market, By Manufacturer share 4. Global Tumor Tracking Systems Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Tumor Tracking Systems Market 5. Supply Side and Demand Side Indicators 6. Global Tumor Tracking Systems Market Analysis and Forecast, 2022-2029 6.1. Global Tumor Tracking Systems Market Size & Y-o-Y Growth Analysis. 7. Global Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 7.1.1. Direct Tumor Tracking Systems 7.1.2. Respiratory Tracking Systems 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Injectable 7.2.2. Oral 7.2.3. Capsules/Tablets 7.2.4. Syrup 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 7.3.1. Hospitals 7.3.2. Cancer Research Institutes 7.3.3. Ambulatory Surgical Centers 7.3.4. Others 8. Global Tumor Tracking Systems Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 9.1.1. Direct Tumor Tracking Systems 9.1.2. Respiratory Tracking Systems 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1 Prostate Cancer 9.2.2 Lung Cancer 9.2.3 Breast Cancer 9.2.4 Others 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 9.3.1. Hospitals 9.3.2. Cancer Research Institutes 9.3.3. Ambulatory Surgical Centers 9.3.4. Others 10. North America Tumor Tracking Systems Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 12. Canada Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 13. Mexico Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 14. Europe Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 15. Europe Tumor Tracking Systems Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 17. France Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 18. Germany Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 19. Italy Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 20. Spain Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 21. Sweden Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 22. CIS Countries Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 23. Rest of Europe Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 24. Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 25. Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 27. India Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 28. Japan Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 29. South Korea Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 30. Australia Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 31. ASEAN Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 32. Rest of Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 33. Middle East Africa Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 34. Middle East Africa Tumor Tracking Systems Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 36. GCC Countries Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 37. Egypt Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 38. Nigeria Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 39. Rest of ME&A Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 40. South America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 41. South America Tumor Tracking Systems Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 43. Argentina Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 44. Rest of South America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Tumor Tracking Systems Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Varian Medical Systems, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Accuray Incorporated 45.3.3. Brainla 45.3.4. Elekta AB 45.3.5. Thermo Fisher Scientific 45.3.6. Miltenyi Biotec 45.3.7. Cell Biolabs, Inc. 45.3.8. STEMCELL Technologies Inc. 45.3.9. QIAGEN 45.3.10. Genekam 45.3.11. Menarini Silicon Biosystems, Inc. 45.3.12. Koninklijke Philips N.V. 45.3.13. CureMD Healthcare 45.3.14. RaySearch Laboratories AB 45.3.15. MICA Information Systems, Inc. 46. Primary Key Insights